Antiinflammatory and immunomodulating properties of fungal metabolites

Mediators of Inflammation

Volumn 2005, Issue 2, 2005, Pages 63-80

  Lull, Cristina ^a   Wichers, Harry J ^a   Savelkoul, Huub F J ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGARICUS BLAZEI EXTRACT; AGARICUS BLAZEI MURILL KYOWA EXTRACT; BETA (1-3) DEXTRO GLUCAN; CYTOKINE; DICHLOROMETHANE; FLAMMULINA VELUPITES PROTEIN; FUCOGALACTAN; FUNGAL PROTEIN; GALACTOMANNAN; GAMMA INTERFERON; GANODERMA LUCIDUM EXTRACT; GANODERMA LUCIDUM POLYSACCHARIDE; GANODERMA LUCIDUM POLYSACCHARIDE 1; GANODERMA LUCIDUM POLYSACCHARIDE 2; GANODERMA LUCIDUM POLYSACCHARIDE 3; GRIFOLAN; KRESTIN; LECTIN; LENTINAN; LEUCYLGLUTAMYLLEUCYLPHENYLALANYLASPARTIC ACID; MAITAKE D FRACTION; PG 101; PHELLINUS LINTEUS POLYSACCHARIDE; SCLEROTINIA SCLEROTIORUM EXTRACT; SCLEROTINIA SCLEROTIORUM GLUCAN; TRITERPENOID; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN LIKE PEPTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VOLVARIELLA VOLVACEA PROTEIN;

AGARICUS BLAZEI; AGROCYBE CYLINDRACEA; ALLERGIC DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CELL MATURATION; CORDYCEPS PRUINOSA; CYTOKINE PRODUCTION; DRUG EFFICACY; EFFECTOR CELL; EHRLICH ASCITES TUMOR; FLAMMULINA VELUPITES; GRIFOLA FRONDOSA; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; LENTINUS LEPIDEUS; LEUKOPENIA; LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MELANOMA; MITOGENICITY; MOLECULAR DYNAMICS; MORCHELLA ESCULENTA; MUSHROOM; NATURAL KILLER CELL; NONHUMAN; PHELLINUS LINTEUS; PLEUROTUS FLORIDA; PLEUROTUS OSTREATUS; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SARCODON ASPRATUS; SPARASSIS CRISPA; TH1 CELL; TH2 CELL; TRICHOLOMA MONGOLICUM; VOLVARIELLA VOLVACEA;

AGARICALES; ANIMALS; ANTI-INFLAMMATORY AGENTS; BETA-GLUCANS; COMPLEMENT ACTIVATION; DENDRITIC CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE SYSTEM; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LYMPHOCYTES;

BASIDIOMYCOTA;

EID: 25644438318     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1155/MI.2005.63     Document Type: Review

References (156)

1. Chang R. Functional properties of edible mushrooms. Nutr Rev. 1996;54(pt 2):S91-S93.
2. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol. 1999;19(1):65-96.
3. Reshetnikov SV, Wasser SP, Tan KK. Higher basidiomycota as a source of antitumor and immunostimulating polysaccharides. Int J Med Mushr. 2001;3(4):361-394.
4. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 2002;60(3):258-274.
5. Borchers AT, Stern JS, Hackman RM, Keen CL, Gershwin ME. Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med. 1999;221(4):281-293.
6. Manzi P, Gambelli L, Marconi S, Vivanti V, Pizzoferrato L. Nutrients in edible mushrooms: an inter-species comparative study. Food Chem. 1999;65:477-482.
7. Mattila P, Suonpaa K, Piironen V. Functional properties of edible mushrooms. Nutrition. 2000;16(7-8):694-696.
8. Smith JE, Rowan NJ, Sullivan R. Medicinal mushrooms: a rapidly developing area of biotechnology for cancer therapy and other bioactivities. Biotechnol Lett. 2002;24(22):1839-1845.
9. Gao Y, Chan E, Zhou S. Immunomodulating activities of Ganoderma, a mushroom with medicinal properties. Food Rev Int. 2004;20:123-161.
10. Breene WM. Nutritional and medicinal value of specialty mushrooms. J Food Prot. 1990;53(10):883-894.
11. Chang ST. World production of cultivated edible and medicinal mushrooms in 1997 with emphasis on Lentinus edodes (Berk) Sing in China. Int J Med Mushr. 1999;1:291-300.
12. Wasser SP, Nevo E, Sokolov D, Reshetnikov S, Timor-Tismenetsky M. Dietary supplements from medicinal mushrooms: diversity of types and variety of regulations. Int J Med Mushr. 2000;2(1):1-19.
13. Hobbs C, LAc. Medicinal Mushrooms: An Exploration of Tradition, Healing and Culture. Santa Cruz, Calif: Botanica Press; 1995.
14. Hobbs C. Medicinal value of Lentinus edodes (Berk) Sing (Agaricomycetideae). A literature review. Int J Med Mushr. 2000;2(4):287-302.
15. Li XM, Huang CK, Zhang TF, et al. The Chinese herbal medicine formula MSSM-002 suppresses allergic airway hyperreactivity and modulates TH1/TH2 responses in a murine model of allergic asthma. J Allergy Clin Immunol. 2000;106(4):660-668.
16. Liu YH, Kao MC, Lai YL, Tsai JJ. Efficacy of local nasal immunotherapy for Dp2-induced airway inflammation in mice: using Dp2 peptide and fungal immunomodulatory peptide. J Allergy Clin Immunol. 2003;112(2):301-310.
17. Liu YH, Tsai CF, Kao MC, Lai YL, Tsai JJ. Effectiveness of Dp2 nasal therapy for Dp2- induced airway inflammation in mice: using oral Ganoderma lucidum as an immunomodulator. J Microbiol Immunol Infect. 2003;36(4):236-242.
18. Hsieh KY, Hsu CI, Lin JY, Tsai CC, Lin RH. Oral administration of an edible-mushroom-derived protein inhibits the development of food-allergic reactions in mice. Clin Exp Allergy. 2003;33(11):1595-1602.
19. Li XM, Zhang TF, Huang CK, et al. Food allergy herbal formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model. J Allergy Clin Immunol. 2001;108(4):639-646.
20. Kuo YC, Huang YL, Chen CC, Lin YS, Chuang KA, Tsai WJ. Cell cycle progression and cytokine gene expression of human peripheral blood mononuclear cells modulated by Agaricus blazei. J Lab Clin Med. 2002;140(3):176-187.
21. Jose N, Ajith TA, Janardhanan KK. Methanol extract of the oyster mushroom, Pleurotus florida, inhibits inflammation and platelet aggregation. Phytother Res. 2004;18(1):43-46.
22. Kim SH, Song YS, Kim SK, Kim BC, Lim CJ, Park EH. Anti-inflammatory and related pharmacological activities of the n-BuOH subfraction of mushroom Phellinus linteus. J Ethnopharmacol. 2004;93(1):141-146.
23. Kim GY, Kim SH, Hwang SY, et al. Oral administration of proteoglycan isolated from Phellinus linteus in the prevention and treatment of collagen-induced arthritis in mice. Biol Pharm Bull. 2003;26(6):823-831.
24. Bobek P, Galbavy S. Hypocholesterolemic and antiatherogenic effect of oyster mushroom (Pleurotus ostreatus) in rabbits. Nahrung. 1999;43(5):339-342.
25. Yamada T, Oinuma T, Niihashi M, et al. Effects of Lentinus edodes mycelia on dietary-induced atherosclerotic involvement in rabbit aorta. J Atheroscler Thromb. 2002;9(3):149-156.
26. Gray AM, Flatt PR. Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). J Endocrinol. 1998;157(2):259-266.
27. Yoon SJ, Yu MA, Pyun YR, et al. The nontoxic mushroom Auricularia auricula contains a polysaccharide with anticoagulant activity mediated by antithrombin. Thromb Res. 2003;112(3):151-158.
28. Nanba H, Kodama N, Schar D, Turner D. Effects of Maitake (Grifola frondosa) glucan in HIV-infected patients. Mycoscience. 2000;41:293-295.
29. Ngai PH, Ng TB. Lentin, a novel and potent antifungal protein from Shiitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemia cells. Life Sci. 2003;73(26):3363-3374.
30. Kodama N, Yamada M, Nanba H. Addition of Maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice. Jpn J Pharmacol. 2001;87(4):327-332.
31. Markova N, Kussovski V, Drandarska I, Nikolaeva S, Georgieva N, Radoucheva T. Protective activity of lentinan in experimental tuberculosis. Int Immunopharmacol. 2003;3(10-11):1557-1562.
32. Kim GY, Roh SI, Park SK, et al. Alleviation of experimental septic shock in mice by acidic polysaccharide isolated from the medicinal mushroom Phellinus linteus. Biol Pharm Bull. 2003;26(10):1418-1423.
33. Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev. 2000;5(1):4-27.
34. Ohno N, Miura NN, Nakajima M, Yadomae T. Antitumor 1,3-β-glucan from cultured fruit body of Sparassis crispa. Biol Pharm Bull. 2000;23(7):866-872.
35. Ohno N, Furukawa M, Miura NN, Adachi Y, Motoi M, Yadomae T. Antitumor β-glucan from the cultured fruit body of Agaricus blazei. Biol Pharm Bull. 2001;24(7):820-828.
36. Fisher M, Yang LX. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res. 2002;22(3):1737-1754.
37. Mahajan RG, Patil SI, Mohan DR, Shastry P. Pleurotus eous mushroom lectin (PEL) with mixed carbohydrate inhibition and antiproliferative activity on tumor cell lines. J Biochem Mol Biol Biophys. 2002;6(5):341-345.
38. Ng ML, Yap AT. Inhibition of human colon carcinoma development by lentinan from Shiitake mushrooms (Lentinus edodes). J Altern Complement Med. 2002;8(5):581-589.
39. Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003;32(3):201-215.
40. Gao YH, Zhou SF. Cancer prevention and treatment by Ganoderma, a mushroom with medicinal properties. Food Rev Int. 2003;19:275-325.
41. Kodama N, Komuta K, Nanba H. Effect of Maitake (Grifola frondosa) D-fraction on the activation of NK cells in cancer patients. J Med Food. 2003;6(4):371-377.
42. Lee IS, Nishikawa A. Polyozellus multiplex, a Korean wild mushroom, as a potent chemopreventive agent against stomach cancer. Life Sci. 2003;73(25):3225-3234.
43. Lee YL, Kim HJ, Lee MS, et al. Oral administration of Agaricus blazei (H1 strain) inhibited tumor growth in a sarcoma 180 inoculation model. Exp Anim. 2003;52(5):371-375.
44. Monro JA. Treatment of cancer with mushroom products. Arch Environ Health. 2003;58(8):533-537.
45. Peng YF, Zhang L, Zeng FB, Xu YX. Structure and antitumor activity of extracellular polysaccharides from mycelium. Carbohyd Polym. 2003;54(3):297-303.
46. Shin KH, Lim SS, Lee S, Lee YS, Jung SH, Cho SY. Anti-tumour and immuno-stimulating activities of the fruiting bodies of Paecilomyces japonica, a new type of Cordyceps spp. Phytother Res. 2003;17(7):830-833.
47. Sliva D. Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther. 2003;2(4):358-364.
48. Tsang KW, Lam CL, Yan C, et al. Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med. 2003;97(6):618-624.
49. Borchers AT, Keen CL, Gershwin ME. Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood). 2004;229(5):393-406.
50. Hattori TS, Komatsu N, Shichijo S, Itoh K. Proteinbound polysaccharide K induced apoptosis of the human Burkitt lymphoma cell line, Namalwa. Biomed Pharmacother. 2004;58(4):226-230.
51. Ho JC, Konerding MA, Gaumann A, Groth M, Liu WK. Fungal polysaccharopeptide inhibits tumor angiogenesis and tumor growth in mice. Life Sci. 2004;75(11):1343-1356.
52. Jiang J, Slivova V, Harvey K, Valachovicova T, Sliva D. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NFκB signaling. Nutr Cancer. 2004;49(2):209-216.
53. Jiang J, Slivova V, Valachovicova T, Harvey K, Sliva D. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol. 2004;24(5):1093-1099.
54. Nakamura T, Matsugo S, Uzuka Y, Matsuo S, Kawagishi H. Fractionation and anti-tumor activity of the mycelia of liquid-cultured Phellinus linteus. Biosci Biotechnol Biochem. 2004;68(4):868-872.
55. Shibata Y, Kurita S, Okugi H, Yamanaka H. Dramatic remission of hormone refractory prostate cancer achieved with extract of the mushroom, Phellinus linteus. Urol Int. 2004;73(2):188-190.
56. Chirigos MA. Immunomodulators: current and future development and application. Thymus. 1992;19 (suppl 1) :S7-S20.
57. Masihi KN. Immunomodulatory agents for prophylaxis and therapy of infections. Int J Antimicrob Agents. 2000;14(3):181-191.
58. Jong SC, Birmingham JM. Medicinal benefits of the mushroom Ganoderma. Adv Appl Microbiol. 1992;37:101-134.
59. Badger AM. Development in industrial microbiology. In: Saratosa FL, Nash CH, Underkofler LA, eds. Proceedings of the Fortieth General Meeting of the Society for Industrial Microbiology. Arlington, Va;1983:274.
60. Vickers A. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest. 2002;20(7-8):1069-1079.
61. Lin H, She YH, Cassileth BR, Sirotnak F, Cunningham Rundles S. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int Immunopharmacol. 2004;4(1):91-99.
62. Jin M, Jung HJ, Choi JJ, et al. Activation of selective transcription factors and cytokines by water-soluble extract from Lentinus lepideus. Exp Biol Med (Maywood). 2003;228(6):749-758.
63. Jin M, Jeon H, Jung HJ, et al. Enhancement of repopulation and hematopoiesis of bone marrow cells in irradiated mice by oral administration of PG101, a water-soluble extract from Lentinus lepideus. Exp Biol Med (Maywood). 2003;228(6):759-766.
64. Harada T, Miura N, Adachi Y, Nakajima M, Yadomae T, Ohn N. Effect of SCG, 1,3-β-D-glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice. Biol Pharm Bull. 2002;25(7):931-939.
65. Sorimachi K, Akimoto K, Ikehara Y, Inafuku K, Okubo A, Yamazaki S. Secretion of TNF-α, IL-8 and nitric oxide by macrophages activated with Agaricus blazei Murill fractions in vitro. Cell Struct Funct. 2001;26(2):103-108.
66. Wang SY, Hsu ML, Hsu HC, et al. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer. 1997;70(6):699-705.
67. Adachi Y, Okazaki M, Ohno N, Yadomae T. Enhancement of cytokine production by macrophages stimulated with (1→3)-β-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull. 1994;17(12):1554-1560.
68. Okazaki M, Adachi Y, Ohno N, Yadomae T. Structure-activity relationship of (1→3)-beta-Dglucans in the induction of cytokine production from macrophages, in vitro. Biol Pharm Bull. 1995;18(10):1320-1327.
69. Ishibashi K, Miura NN, Adachi Y, Ohno N, Yadomae T. Relationship between solubility of grifolan, a fungal 1,3-β-D-glucan, and production of tumor necrosis factor by macrophages in vitro. Biosci Biotechnol Biochem. 2001;65(9):1993-2000.
70. Sanzen I, Imanishi N, Takamatsu N, et al. Nitric oxide-mediated antitumor activity induced by the extract from Grifola frondosa (Maitake mushroom) in a macrophage cell line, RAW264.7. J Exp Clin Cancer Res. 2001;20(4):591-597.
71. Duncan CJ, Pugh N, Pasco DS, Ross SA. Isolation of a galactomannan that enhances macrophage activation from the edible fungus Morchella esculenta. J Agric Food Chem. 2002;50(20):5683-5685.
72. Han SB, Lee CW, Jeon YJ, et al. The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis. Immunopharmacology. 1999;41(2):157-164.
73. Kim GY, Oh YH, Park YM. Acidic polysaccharide isolated from Phellinus linteus induces nitric oxide-mediated tumoricidal activity of macrophages through protein tyrosine kinase and protein kinase C. Biochem Biophys Res Commun. 2003;309(2):399-407.
74. Kim KM, Kwon YG, Chung HT, et al. Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-κB activation. Toxicol Appl Pharmacol. 2003;190(1):1-8.
75. Mizuno M, Shiomi Y, Minato K, Kawakami S, Ashida H, Tsuchida H. Fucogalactan isolated from Sarcodon aspratus elicits release of tumor necrosis factor-α and nitric oxide from murine macrophages. Immunopharmacology. 2000;46(2):113-121.
76. Kurashige S, Akuzawa Y, Endo F. Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacol Immunotoxicol. 1997;19(2):175-183.
77. Ngai PH, Wang HX, Ng TB. Purification and characterization of a ubiquitin-like peptide with macrophage stimulating, antiproliferative and ribonuclease activities from the mushroom Agrocybe cylindracea. Peptides. 2003;24(5):639-645.
78. Wang HX, Ng TB, Ooi VE, Liu WK, Chang ST. Actions of lectins from the mushroom Tricholoma mongolicum on macrophages, splenocytes and lifespan in sarcoma-bearing mice. Anticancer Res. 1997;17(1A):419-424.
79. Miller JS. Biology of natural killer cells in cancer and infection. Cancer Invest. 2002;20(3):405-419.
80. Sepulveda C, Puente J. Natural killer cells and the innate immune system in infectious pathology. Rev Med Chil. 2000;128(12):1361-1370.
81. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol. 2004;22:405-429.
82. Kodama N, Komuta K, Sakai N, Nanba H. Effects of D-fraction, a polysaccharide from Grifola frondosa on tumor growth involve activation of NK cells. Biol Pharm Bull. 2002;25(12):1647-1650.
83. Kodama N, Kakuno T, Nanba H. Stimulation of the natural immune system in normal mice by polysaccharide from Maitake mushroom. Mycoscience. 2003;44(3):257-261.
84. Kodama N, Murata Y, Nanba H. Administration of a polysaccharide from Grifola frondosa stimulates immune function of normalmice. J Med Food. 2004;7(2):141-145.
85. Takimoto H, Wakita D, Kawaguchi K, Kumazawa Y. Potentiation of cytotoxic activity in naive and tumor-bearing mice by oral administration of hotwater extracts from Agaricus brazei fruiting bodies. Biol Pharm Bull. 2004;27(3):404-406.
86. Emtage PC, Clarke D, Gonzalo-Daganzo R, Junghans RP. Generating potent Th1/Tc1 T cell adoptive immunotherapy doses using human IL-12: harnessing the immunomodulatory potential of IL-12 without the in vivo-associated toxicity [published correction appears in J Immunother]. J Immunother. 2003;26(2):97-106.
87. Emtage PC, Clarke D, Gonzalo-Daganzo R, Junghans RP. J Immunother. 2003;26(3):290.
88. Kaneno R, Fontanari LM, Santos SA, Di Stasi LC, Rodrigues Filho E, Eira AF. Effects of extracts from Brazilian sun-mushroom (Agaricus blazei) on the NK activity and lymphoproliferative responsiveness of Ehrlich tumor-bearing mice. Food Chem Toxicol. 2004;42(6):909-916.
89. Ahn WS, Kim DJ, Chae GT, et al. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int J Gynecol Cancer. 2004;14(4):589-594.
90. Zhang W, Wang Y, Hou Y. Effects of Chinese medicinal fungus water extract on tumor metastasis and some parameters of immune function. Int Immunopharmacol. 2004;4(3):461-468.
91. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811.
92. Cao LZ, Lin ZB. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol Lett. 2002;83(3):163-169.
93. Park SK, Kim GY, Lim JY, et al. Acidic polysaccharides isolated from Phellinus linteus induce phenotypic and functional maturation of murine dendritic cells. Biochem Biophys Res Commun. 2003;312(2):449-458.
94. Kim GY, Han MG, Song YS, et al. Proteoglycan isolated from Phellinus linteus induces toll-like receptors 2- and 4-mediated maturation of murine dendritic cells via activation of ERK, p38, and NF-kappaB. Biol Pharm Bull. 2004;27(10):1656-1662.
95. + DC and type I helper T cell-dominant immune state. FEBS Lett. 2004;576(3):391-400.
96. Kanazawa M, Mori Y, Yoshihara K, et al. Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes. Immunol Lett. 2004;91(2-3):229-238.
97. Di Luzio NR. Update on the immunomodulating activities of glucans. Springer Semin Immunopathol. 1985;8(4):387-400.
98. Ross GD, Vetvicka V, Yan J, Xia Y, Vetvickova J. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology. 1999;42(1-3):61-74.
99. Alper CA, Abramson N, Johnston RB Jr, Jandl JH, Rosen FS. Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N Engl J Med. 1970;282(7):350-354.
100. Winkelstein JA, Smith MR, Shin HS. The role of C3 as an opsonin in the early stages of infection. Proc Soc Exp Biol Med. 1975;149(2):397-401.
101. Okuda T, Yoshioka Y, Ikekawa T, Chihara G, Nishioka K. Anticomplementary activity of antitumor polysaccharides. Nature: New Biol. 1972;238(12):59-60.
102. Hamuro J, Hadding U, Bitter-Suermann D. Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumor regressing activity. Immunology. 1978;34(4):695-705.
103. Shimizu S, Kitada H, Yokota H, et al. Activation of the alternative complement pathway by Agaricus blazei Murill. Phytomedicine. 2002;9(6):536-545.
104. Lee JW, Chung CH, Jeong H, Lee KH. Effects of alkali extract of Ganoderma lucidum IY007 on complement system. Korean J Mycol. 1990;18:137-144.
105. Min BS, Gao JJ, Hattori M, Lee HK, Kim YH. Anticomplement activity of terpenoids from the spores of Ganoderma lucidum. Planta Med. 2001;67(9):811-814.
106. Yang QY, Pai SS. The anti-ageing effects of Ganoderma essence. Proceedings of the International Meeting on Ganoderma Science. Beijing; 2000:30.
107. Suzuki I, Hashimoto K, Oikawa S, Sato K, Osawa M, Yadomae T. Antitumor and immunomodulating activities of a beta-glucan obtained from liquid-cultured Grifola frondosa. Chem Pharm Bull (Tokyo). 1989;37(2):410-413.
108. Jeong H, Lee JW, Lee KH. Studies on the anticomplementary activity of Korean higher fungi. Korean J Mycol. 1990;18:145-148.
109. Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378(6552):88-91.
110. Micallef MJ, Ohtsuki T, Kohno K, et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol. 1996;26(7): 1647-1651.
111. + T cells through IL-12 produced by Listeria-induced macrophages. Science. 1993;260(5107):547-549.
112. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397-440.
113. + T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens. Cancer Res. 1994;54(4):1055-1058.
114. O'Garra A,Murphy K. T-cell subsets in autoimmunity. Curr Opin Immunol. 1993;5(6):880-886.
115. Powrie F, Coffman RL. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today. 1993;14(6):270-274.
116. Scott B, Liblau R, Degermann S, et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity. 1994;1(1):73-83.
117. + T cells in the pathogenesis of organspecific autoimmune diseases. Immunol Today. 1995;16(1):34-38.
118. Romagnani S. Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol. 1994;6(6):838-846.
119. Suzuki Y, Adachi Y, Ohno N, Yadomae T. Th1/Th2-balancing immunomodulating activity of gelforming (1→3)-β-glucans from fungi. Biol Pharm Bull. 2001;24(7):811-819.
120. Chihara G, Hamuro J, Maeda YY, et al. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview. Cancer Detect Prev Suppl. 1987;1:423-443.
121. Murata Y, Shimamura T, Tagami T, Takatsuki F, Hamuro J. The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int Immunopharmacol. 2002;2(5):673-689.
122. Inoue A, Kodama N, Nanba H. Effect of Maitake (Grifola frondosa) D-fraction on the control of the T lymph node Th-1/Th-2 proportion. Biol Pharm Bull. 2002;25(4):536-540.
123. Harada N, Kodama N, Nanba H. Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice. Cancer Lett. 2003;192(2):181-187.
124. Hsu HC, Hsu CI, Lin RH, Kao CL, Lin JY. Fip-vvo, a new fungal immunomodulatory protein isolated from Volvariella volvacea. Biochem J. 1997;323(pt 2):557-565.
125. She QB, Ng TB, Liu WK. A novel lectin with potent immunomodulatory activity isolated from both fruiting bodies and cultured mycelia of the edible mushroom Volvariella volvacea. Biochem Biophys Res Commun. 1998;247(1):106-111.
126. Bao XF, Wang XS, Dong Q, Fang JN, Li XY. Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry. 2002;59(2):175-181.
127. Bao X, Fang J, Li X. Structural characterization and immunomodulating activity of a complex glucan from spores of Ganoderma lucidum. Biosci Biotechnol Biochem. 2001;65(11):2384-2391.
128. Zhang J, Tang Q, Zimmerman-Kordmann M, Reutter W, Fan H. Activation of B lymphocytes by GLIS, a bioactive proteoglycan fromGanoderma lucidum. Life Sci. 2002;71(6):623-638.
129. Kim GY, Park SK, Lee MK, et al. Proteoglycan isolated from Phellinus linteus activates murine B lymphocytes via protein kinase C and protein tyrosine kinase. Int Immunopharmacol. 2003;3(9):1281-1292.
130. Di Renzo L, Yefenof E, Klein E. The function of human NK cells is enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18). Eur J Immunol. 1991;21(7):1755-1758.
131. Kino K, Sone T, Watanabe J, et al. Immunomodulator, LZ-8, prevents antibody production in mice. Int J Immunopharmacol. 1991;13(8):1109-1115.
132. Ko JL, Hsu CI, Lin RH, Kao CL, Lin JY. A new fungal immunomodulatory protein, FIP-fve isolated from the edible mushroom, Flammulina velutipes and its complete amino acid sequence. Eur J Biochem. 1995;228(2):244-249.
133. Janeway CA Jr, Medzhitov R. Lipoproteins take their toll on the host. Curr Biol. 1999;9(23):R879-R882.
134. Mueller A, Raptis J, Rice PJ, et al. The influence of glucan polymer structure and solution conformation on binding to (1→3)-β-D-glucan receptors in a human monocyte-like cell line. Glycobiology. 2000;10(4):339-346.
135. Lowe E, Rice P, Ha T, et al. A (1→3)-β-D-linked heptasaccharide is the unit ligand for glucan pattern recognition receptors on human monocytes. Microbes Infect. 2001;3(10):789-797.
136. Kougias P, Wei D, Rice PJ, et al. Normal human fibroblasts express pattern recognition receptors for fungal (1→3)-β-D-glucans. Infect Immun. 2001;69(6):3933-3938.
137. Brown GD, Gordon S. Fungal β-glucans and mammalian immunity. Immunity. 2003;19(3):311-315.
138. Ross GD, Cain JA, Myones BL, Newman SL, Lachmann PJ. Specificity of membrane complement receptor type three (CR3) for beta-glucans. Complement. 1987;4(2):61-74.
139. Zimmerman JW, Lindermuth J, Fish PA, Palace GP, Stevenson TT, DeMong DE. A novel carbohydrateglycosphingolipid interaction between a β-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J Biol Chem. 1998;273(34):22014-22020.
140. Rice PJ, Kelley JL, Kogan G, et al. Human monocyte scavenger receptors are pattern recognition receptors for (1→3)-β-D-glucans. J Leukoc Biol. 2002;72(1):140-146.
141. Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature. 2001;413(6851):36-37.
142. Shao BM, Dai H, Xu W, Lin ZB, Gao XM. Immune receptors for polysaccharides from Ganoderma lucidum. Biochem Biophys Res Commun. 2004;323(1):133-141.
143. Herre J, Gordon S, Brown GD. Dectin-1 and its role in the recognition of β-glucans by macrophages. Mol Immunol. 2004;40(12):869-876.
144. Taylor PR, Brown GD, Reid DM, et al. The β-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol. 2002;169(7):3876-3882.
145. Kim HM, Han SB, Oh GT, et al. Stimulation of humoral and cell mediated immunity by polysaccharide from mushroom Phellinus linteus. Int J Immunopharmacol. 1996;18(5):295-303.
146. Liu M, Li J, Kong F, Lin J, Gao Y. Induction of immunomodulating cytokines by a new polysaccharide-peptide complex from culture mycelia of Lentinus edodes. Immunopharmacology. 1998;40(3):187-198.
147. Bao X, Liu C, Fang J, Li X. Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr) Karst. Carbohydr Res. 2001;332(1):67-74.
148. Hsiao WL, Li YQ, Lee TL, Li N, You MM, Chang ST. Medicinal mushroom extracts inhibit ras-induced cell transformation and the inhibitory effect requires the presence of normal cells. Carcinogenesis. 2004;25(7):1177-1183.
149. Shigesue K, Kodama N, Nanba H. Effects of Maitake (Grifola frondosa) polysaccharide on collagen-induced arthritis in mice. Jpn J Pharmacol. 2000;84(3):293-300.
150. Han SN, Wu D, Leka LS, Meydani SN. Effect of mushroom (Coriolus versicolor) extract on the immune response of young and old mice. FASEB J. 1996;10(3):3200.
151. Chihara G, Hamuro J, Maeda Y, Arai Y, Fukuoka F. Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk) Sing (an edible mushroom). Cancer Res. 1970;30(11):2776-2781.
152. Suga T, Shiio T, Maeda YY, Chihara G. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. Cancer Res. 1984;44(11):5132-5137.
153. Ooi VE, Liu F. Immunomodulation and anticancer activity of polysaccharide-protein complexes. Curr Med Chem. 2000;7(7):715-729.
154. Cui J, Chisti Y. Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. Biotechnol Adv. 2003;21(2):109-122.
155. Yang QY, Jong SC, Li XY, Zhou JX, Chen RT, Xu LZ. Antitumor and immunomodulating activities of the Polysaccharide-Peptide (Psp) of Coriolus versicolor. Eos-Riv Immunol. 1992;12:29-34.
156. Zhu R, Chen X, Lan J. Advance in the study on liquid fermentation for medicinal fungi. Zhong Yao Cai. 2003;26(1):55-57.